Чтение онлайн

150. Strieter R. M., Polverini P. J., Kunkel S. L., Arenberg D. A., Burdick M. D., Kasper J….Shanafelt A. B.. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem., 1995, Vol. 270, no. 45, pp.27348–27357. doi: 10.1074/jbc.270.45.27348.

151. Suzuki, F., Kubota T., Miyazaki Y., Ishikawa K., Ebisawa M., Hirohata S……Nanki T. Serum level of soluble CX3CL1/ fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity. Arthritis Res. Ther., 2012, Vol. 14, no.2, R48. doi: 10.1186/ar3761.

152. Swiecki M., Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol., 2015, Vol. 15, no 8, pp. 471–485. doi: 10.1038/nri3865.

153. Szekanecz Z., Halloran M. M., Haskell C. J. Mediators of angiogenesis: the role of cellular adhesion molecules. Trends Glycosci. Glycotechnol, (TIGG). 1999, 58: 73.

154. Szekanecz Z., Koch A. E. Macrophages and their products in rheumatoid arthritis. Curr. Opin. Rheumatol., 2007,Vol. 19, no.3, pp. 289–295.doi: 10.1097/BOR.0b013e32805e87ae.

155. Szekanecz Z., Koch A. E., Angiogenesis in rheumatoid arthritis. In: Rubanyi G. M., ed. Angiogenesis in health and disease. Marcel Dekker, New York, Basel. 2000; pp 429–450.

156. Szekanecz Z., Koch A. E., Chemokines and angiogenesis. Curr. Opin. Rheumatol., 2001, Vol. 13, no.3, pp. 202–208. doi: 10.1097/00002281–200105000–00009.

157. Szekanecz Z., Szegedi G., Koch A. E. Angiogenesis in rheumatoid arthritis. J. Invest. Med., 1998, Vol. 46, no. 2, pp.27–41.

158. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M….Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum., 2003, Vol. 48, no. 4, pp. 971–981. doi: 10.1002/art.10859.

159. Tengner P., Halse A-K., Haga H-J., Jonsson R., Wahren- Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB auto-antibody-producing cells in salivary glands from patients with SjoEgren's syndrome. Arthritis Rheum., 1998, Vol. 41, no. 12, pp.2238–2248. doi: 10.1002/1529–0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V.

160. Thurlings R. M., Wijbrandts C. A., Mebius R. E., Cantaert T., Dinant H. J., Teneke C. T., der Pouw-Kraan M., Verweij C. L., Baeten D., Tak P. P. Synovial Lymphoid Neogenesis Does Not Define a Specific Clinical Rheumatoid Arthritis Phenotype. ARTHRITIS & RHEUMATISM, 2008, Vol. 58, no. 6, pp. 1582–1589. doi: 10.1002/art.23505.

161. Turunen S., Huhtakangas J., Nousiainen T.. Valkealahti M., Melkko J., Risteli J., Lehenkari P. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue. Arthritis Research & Therapy, 2016, 18:239. doi 10.1186/s13075–016–1140–9.

162. Ulfgren A. K., Grundtman C., Borg K., Alexanderson H., Andersson U., Harris H. E. Lundberg I. E. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum., 2004, Vol. 50, no. 5., pp.1586–1594. doi: 10.1002/art.20220.

163. Van der Aa E., van Montfoort N., Woltman A. M. BDCA3+CLEC9A+human dendritic cell function and development. Semin. Cell Dev. Biol., 2015, 41:39–48. doi: 10.1016/j.semcdb.2014.05.016.

164. van der Woude D., Lie B. A., Lundstrom E., Balsa A., Feitsma A. L., Houwing-Duistermaat J.J….. Toes R. E. Protection against anti- citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA- DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheumatol., 2010, Vol. 62, no.5, pp.1236–1245. doi: 10.1002/art.27366.

165. Veale D. J., Fearon U. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract. Res. Clin. Rheumatol., 2006, Vol.20, no.5, pp. 941–947. doi: 10.1016/j.berh.2006.05.004.

166. Vogel D. Y., Glim J. E., Stavenuiter A. W., Breur M., Heijnen P., Amor S., Dijkstra C. D., Beelen R. H. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology, 2014, Vol. 219, no. 9, pp. 695–703. doi: 10.1016/j.imbio.2014.05.002.

167. Voll R. E., Urbonaviciute V., Herrmann M., Kalden J. R. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr. Med. Assoc. J., 2008, no.10, pp. 26–28.

168. Williams. G. T., Williams W. J. Granulomatous inflammation – a review. J. Clin. Pathol… 1983, Vol. 3, no. 7, pp. 723–733. doi: 10.1136/jcp.36.7.723.

169. Wu L., Fan J., Matsumoto S., Watanabe T. Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages. Biochemical and Biophysical Research Communications, 2000, Vol. 269, no.3, pp. 808–815. doi.org/10.1006/bbrc.2000.2368.

170. Wynn T. A., Vannella K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity, 2016; Vol. 44, no. 3, 450–462. doi: 10.1016/j.immuni.2016.02.015.

171. Yamanaka H. TNF as a target of inflammation in rheumatoid arthritis. Endocr. Metab. Immune, 2015, Vol. 15, pp. 129–134. doi: 10.2174/1871530315666150316121808.

172. Yang B. G., Tanaka T., Jang M. H., Bai Z., Hayasaka H., Miyasaka M. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J Immunol., 2007, Vol.179, no. 7, pp. 4376–4382. doi: 10.4049/jimmunol.179.7.4376.

173. Young C. L., Adamson T. C., Vaughan J. H., Fox R. I. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum., 1984, Vol. 27, no. 1, pp. 32–39. https://sci-hub.do/10.1002/art.1780270106.

174. Zhu H., Fang X., Zhang D., Wu W., Shao M., Wang L., Gu L. Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen. Apoptosis, 2016, Vol. 21, no. 1, pp. 96–109. doi: 10.1007/s10495–015–1187–0.